Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Euthyrox for Secondary Hypothyroidism in Intracerebral Hemorrhage
NCT06353555Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of levothyroxine sodium in secondary hypothyroidism (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Blood Pressure at Day 7, Cerebral Blood Flow Dynamics at Day 7 and 2 more. Started Oct 2023; status: recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
secondary hypothyroidism
Beyond the preview
Go deeper on NCT06353555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06353555.